Parkin regulates neuronal lipid homeostasis through SREBP2-lipoprotein lipase pathway—implications for Parkinson’s disease
Human Molecular Genetics · 2023
DOI: 10.1093/hmg/ddac297 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2023. Verfasst von Willcyn Tang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore. Hauptthemen laut MEDLINE: Lipoprotein Lipase, Parkinson Disease, Sterol Regulatory Element Binding Protein 2, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Khoo Pilot Award, National Medical Research Council-Translational and Clinical Research, Singapore Ministry of Health Open Fund-Large Collaborative.
Abstract (Originalsprache)
Abnormal lipid homeostasis has been observed in the brain of Parkinson’s disease (PD) patients and experimental models, although the mechanism underlying this phenomenon is unclear. Notably, previous studies have reported that the PD-linked protein Parkin functionally interacts with important lipid regulators, including Sterol Regulatory Element-Binding Proteins (SREBPs) and cluster of differentiation 36 (CD36). Here, we demonstrate a functional relationship between Parkin and lipoprotein lipase (LPL), a triglyceride lipase that is widely expressed in the brain. Using a human neuroblastoma cell line and a Parkin knockout mouse model, we demonstrate that Parkin expression level positively correlates with neuronal LPL protein level and activity. Importantly, our study identified SREBP2, a major regulator of sterol and fatty acid synthesis, as a potential mediator between Parkin and LPL. Supporting this, SREBP2 genetic ablation abolished Parkin effect on LPL expression. We further demonstrate that Parkin-LPL pathway regulates the formation of intracellular lipid droplets, and that this pathway is upregulated upon exposure to PD-linked oxidative stress induced by rotenone. Finally, we show that inhibition of either LPL or SREBP2 exacerbates rotenone-induced cell death. Taken together, our findings reveal a novel pathway linking Parkin, SREBP2 and LPL in neuronal lipid homeostasis that may be relevant to the pathogenesis of PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Research, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore.
- Department of Research, National Neuroscience Institute, Singapore 308433, Singapore.
- Graduate School of Integrative Sciences and Engineering, National University of Singapore, Singapore 119077, Singapore.
- Department of Pharmacology and Cancer Biology, Duke School of Medicine, Duke University, Durham, NC 27710, USA.
- Department of Brain Sciences, Imperial College London, London SW7 2AZ, UK.
ORCID-Profile: Teddy J W Tng
Förderung
- Khoo Pilot Award
- National Medical Research Council-Translational and Clinical Research
- Singapore Ministry of Health Open Fund-Large Collaborative
Zitieren
APA
Tang, W., Thundyil, J., Lim, G. G. Y., Tng, T. J. W., Yeow, S. Q. Z., Nair, A., Chai, C., Yao, T. P., & Lim, K. L. (2023). Parkin regulates neuronal lipid homeostasis through SREBP2-lipoprotein lipase pathway—implications for Parkinson’s disease. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddac297
Vancouver
Tang W, Thundyil J, Lim GGY, Tng TJW, Yeow SQZ, Nair A, et al. Parkin regulates neuronal lipid homeostasis through SREBP2-lipoprotein lipase pathway—implications for Parkinson’s disease. Human Molecular Genetics. 2023. doi:10.1093/hmg/ddac297
BibTeX
@article{Tang2023,
author = {Tang, Willcyn and Thundyil, John and Lim, Grace Gui Yin and Tng, Teddy J W and Yeow, Sean Qing Zhang and Nair, Aditya and Chai, Chou and Yao, Tso-Pang and Lim, Kah-Leong},
title = {Parkin regulates neuronal lipid homeostasis through SREBP2-lipoprotein lipase pathway—implications for Parkinson’s disease},
journal = {Human Molecular Genetics},
year = {2023},
doi = {10.1093/hmg/ddac297}
}
EUVIMED